DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH

Urological Research

Volumn 25, Issue SUPPL. 1, 1997, Pages

  Sauter, G ^a   Gasser, T C ^a   Moch, H ^a   Richter, J ^a   Jiang, F ^a   Albrecht, R ^a   Novotny, H ^a   Wagner, U ^a   Bubendorf, L ^a   Mihatsch, M J ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

aneuploidy; bladder neoplasms; chromosome 1; chromosome 17; chromosome 7; chromosome 9; chromosome X; chromosome Y; flow cytometry; fluorescence in situ hydridization

Indexed keywords

ARTICLE; BLADDER CANCER; CHROMOSOME ABERRATION; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 7; CHROMOSOMES, HUMAN, PAIR 9; EVALUATION STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; PLOIDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS; X CHROMOSOME; Y CHROMOSOME;

EID: 8044251510     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00942046     Document Type: Article

References (27)

1. Blomjous EC, Schipper NW, Baak JP, Vos W, De Voogt HJ, Meijer CJ (1989) The value of morphometry and DNA flow cytometry in addition to classic prognosticators in superficial urinary bladder carcinoma. Am J Clin Pathol 91:243
2. Dalbagni G, Presti J, Reuter V, Zhang Z-F, Fair W, Sarkis A, Cordon-Cardo C (1993) Molecular genetic alterations of chromosome 17 and p53 nuclear overexpression in human bladder cancer. Diagn Mol Pathol 2:4
3. Esrig D, Spruck CHI, Nichols PW, Chaiwun B, Steven K, Groshen S, Chen SC, Skinner DG, Jones PA, Cote RJ (1993) p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143:1389
4. Giaretti W (1994) A model of DNA aneuploidization and evolution in colorectal cancer. Lab Invest 71:904
5. Gustafson H,Tribukait B (1985) Characterization of bladder carcinomas by flow DNA analysis. Eur Urol 11:410
6. Gustafson H, Tribukait B, Esposti P (1982) DNA profile and tumor progression in patients with superficial bladder cancer. Urol Res 10:13
7. Hopman A, Ramaekers F, Raap A, Beck J, Devilee P, van der Ploeg M, Vooijs G (1988) In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry 89:307
8. Hopman A, Poddighe P, Smeets A, Moesker O, Beck J, Vooijs G, Ramaekers F (1989) Detection of numerical chromosome aberrations in bladder cancer by in situ hybridization. Am J Pathol 135:1105
9. Hopman A, Moesker O, Smeets A, Pauwels R, Vooijs G, Ramaekers F (1991) Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res 51:644
10. Kallioniemi O, Kallioniemi A, Kurisu W, Thor A, Chen L, Smith H, Waldman F, Pinkel D, Gray J (1992) C-erB-2 oncogene amplification in breast cancer analyzed by fluorescence in situ hybridization. Proc Natl Acad Sci USA 89:5321
11. Kamb A, Gruis N, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian S, Stockert E, Day III R, Johnson B, Skolnick M (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436
12. Koss L, Deitch D, Ramanathan R, Sherman A (1985) Diagnostic value of cytology of voided urine. Acta Cytol 29:810
13. Miyamoto H, Kubota Y, Shuin T, Torigoe S, Hosaka M, Iwasaki Y, Danenberg K, Danenberg PV (1993) Analyses of p53 gene mutations in primary human bladder cancer. Oncol Res 5:6
14. Mostofi F (1973) Histological typing of urinary bladder tumors. World Health Organization, Geneva
15. Olumi A, Tsai Y, Nichols P, Skinner D, Cain D, Bender L, Jones P (1990) Allelic loss of chromosome 17p distinguishes high grade from low grade transitional cell carcinomas of the bladder. Cancer Res 50:7081
16. Ruppert J, Tokino T, Sidransky D (1993) Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53:5093
17. Sandberg A, Berger C (1994) Review of chromosome studies in urological tumors. II. Cytogenetics and molecular genetics of bladder cancer. J Uroll 51:545
18. Sauter G, Moch H, Moore D, Carroll P, Kerschmann R, Chew K, Mihatsch M, Gudat F, Waldman F (1993) Heterogeneity of erbB-2 gene amplification in bladder cancer. Cancer Res 53: 2199
19. Sauter G, Deng G, Moch H,Kerschmann R, Matsumura K, DeVries S, George T, Fuentes J, Carroll P, Mihatsch M, Waldman F (1994) Physical deletion of the p53 gene in bladder cancer: Detection by fluorescence in situ hybridization. Am J Pathol 144:756
20. Sauter G, Carroll P, Moch H, Kallioniemi A, Kurschmann R, Narayam P, Mihatsch M, Waldman F (1995) Increased c-myc gene copy number in advanced bladder cancer. Am J Pathol 146:1131
21. Sauter G, Moch H, Carroll P, Kurschmann R, Mihatsch M, Waldman F (1995) Chromosome 9 loss detected by fluorescence in situ hybridization. Int J Cancer 64:99
22. Sauter G, Moch H, Wagner U, Novotna H, Gasser T, Mattarelli G, Mihatsch M, Waldman F (1995) Y Chromosome loss detected by FISH in bladder cancer. Cancer Gen Cytogen 82:163
23. Tribukait B (1987) Flow cytometry in assessing the clinical aggressiveness of genitourinary neoplasms. World J Urol 5:108
24. Tribukait B, Gustafson H, Esposti P (1982) The significance of ploidy and proliferation in the clinical evaluation of bladder tumors. Br J Urol 54:130
25. UICC (1978) TNM classification of malignant tumours. International Union against Cancer, Geneva
26. Wheeless LL, Badalament RA, DeVere WRW, Fradet Y, Tribukait B (1993) Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry 14:478
27. Williamson MP, Elder PA, Knowles MA (1994) The spectrum of TP53 mutations in bladder carcinoma. Genes Chromosom Cancer 9:108